Big Phar­ma ad spend­ing edges to­ward $7B with Sanofi, Re­gen­eron and No­vo Nordisk lead­ing the way

4 years ago
R&D
Pharma

Bio­gen, Ei­sai un­veil new da­ta on lecanemab, but ques­tions linger on ARIA-E; Spa­tial bi­ol­o­gy out­fit grabs $33M round

4 years ago
News Briefing

Sanofi CEO Paul Hud­son con­tin­ues hunt for new tech, spear­ing a deal with organoid start­up

4 years ago
Deals

In aim­ing to by­pass CRISPR's de­liv­ery is­sues, one start­up eyes the gene edit­ing Spot­light

4 years ago
Financing
Startups

Ali­gos chops off a he­pati­tis B pro­gram — again — af­ter a pa­tient was briefly hos­pi­tal­ized

4 years ago
R&D

FDA forced to re­set how it reg­u­lates some oph­thalmic drugs fol­low­ing court loss

4 years ago
FDA+

No­var­tis takes next step in Rus­sia, halt­ing new tri­als and en­roll­ment as Big Phar­ma re­sponds to Ukraine in­va­sion

4 years ago
Pharma

Seat­tle-based Covid-19 vac­cine de­vel­op­er seeks $950M from In­di­an part­ner over trade se­cret theft

4 years ago
Coronavirus
Law

In year 3 of the pan­dem­ic, a new Covid-19 biotech takes flight with an an­ti­body com­bo and Takeda's ex-vac­cines chief ...

4 years ago
Financing
Startups

A new cell ther­a­py start­up from an im­munother­a­py pi­o­neer rais­es $175M in KRAS quest

4 years ago
Financing

With lat­est Keytru­da OK, Mer­ck edges in­to Glax­o­SmithK­line’s (small) PD-1 turf

4 years ago
Pharma
FDA+

Anap­tys­Bio CEO abrupt­ly re­signs less than a week af­ter mid-stage flop

4 years ago
People

Putting Bio­gen's Aduhelm cri­sis be­hind him, Al San­drock grabs CEO role at gene ther­a­py play­er to lead turn­around ...

4 years ago
People

Covid vac­cines and drugs are free. But for many im­muno­com­pro­mised pa­tients, pro­tec­tion comes at a cost

4 years ago
Coronavirus
In Focus

Pfiz­er scores an 'A' on gen­der and racial pay eq­ui­ty re­port, while Bio­gen flunks

4 years ago
Pharma

Covid vac­cine patent land­scape heats up as Pfiz­er's part­ner sues Ar­bu­tus and Genevant

4 years ago
Pharma
Coronavirus

Klick Health read­ies for 25th an­niver­sary, tap­ping new tal­ent and ex­pand­ing prac­tices

4 years ago
Pharma
Marketing

'Wait, what?' First TV ad for Ab­b­Vie’s Vuity pres­by­opia eye drops high­lights com­mon sur­prised re­ac­tion

4 years ago
Pharma
Marketing

Lon­za inks deal with first cus­tomer at re­cent­ly-ex­pand­ed Chi­na man­u­fac­tur­ing site

4 years ago
Pharma
Manufacturing

Eli Lil­ly chief Dave Ricks rides a win­ning sea­son to a rich, $21.5M pay pack­age as suc­cess­es out­weigh set­backs

4 years ago
R&D

Af­ter ac­qui­si­tions and new deals, Re­cro re­brands to So­ci­etal CD­MO

4 years ago
Pharma
Manufacturing

Cadi­la's ster­ile in­jectable site in In­dia hit with a Form 483 fol­low­ing a rare in­ter­na­tion­al in­spec­tion for FDA

4 years ago
FDA+
Manufacturing

Covid-19 roundup: FDA plans Covid-19 boost­er ad­comm but Pfiz­er and Mod­er­na's apps won't be dis­cussed

4 years ago
Coronavirus

Go­ing...go­ing...gone. A small biotech throws in its IPO cards af­ter mar­ket melt­down

4 years ago
Financing
First page Previous page 554555556557558559560 Next page Last page
A service from the Financial Times